Bioinformatics Analyses Identify the Therapeutic Potential of ST8SIA6 for Colon Cancer
Authors:
- Chou-Yuan KoCKChou-Yuan Ko
- Tian-Huei ChuTian-Huei Chu
- Ching-Cheng HsuCHChing-Cheng Hsu
- Hsin-Pao ChenHCHsin-Pao Chen
- Shih-Chung HuangSHShih-Chung Huang
- Chen-Lin ChangCCChen-Lin Chang
- Shiow-Jyu TzouSTShiow-Jyu Tzou
- Tung-Yuan ChenTCTung-Yuan Chen
- Chia-Chen LinCLChia-Chen Lin
- Pei-Chun ShihPSPei-Chun Shih
- Chung-Hsien LinCLChung-Hsien Lin
- Chuan-Fa ChangCCChuan-Fa Chang
Open Access
- 4 March 2022
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (3) , 401
Abstract
Sialylation of glycoproteins is modified by distinct sialyltransferases such as ST3Gal, ST6Gal, ST6GalNAc, or ST8SIA with α2,3-, α2,6-, or α2,8-linkages. Alteration of these sialyltransferases causing aberrant sialylation is associated with the progression of colon cancer. However, among the ST8- sialyltransferases, the role of ST8SIA6 in colon cancer remains poorly understood. In this study, we explored the involvement of ST8SIA6 in colon cancer using multiple gene databases. The relationship between ST8SIA6 expression and tumor stages/grades was investigated by UALCAN analysis, and Kaplan–Meier Plotter analysis was used to analyze the expression of ST8SIA6 on the survival outcome of colon cancer patients. Moreover, the biological functions of ST8SIA6 in colon cancer were explored using LinkedOmics and cancer cell metabolism gene DB. Finally, TIMER and TISMO analyses were used to delineate ST8SIA6 levels in tumor immunity and immunotherapy responses, respectively. ST8SIA6 downregulation was associated with an advanced stage and poorly differentiated grade; however, ST8SIA6 expression did not affect the survival outcomes in patients with colon cancer. Gene ontology analysis suggested that ST8SIA6 participates in cell surface adhesion, angiogenesis, and membrane vesicle trafficking. In addition, ST8SIA6 levels affected immunocyte infiltration and immunotherapy responses in colon cancer. Collectively, these results suggest that ST8SIA6 may serve as a novel therapeutic target towards personalized medicine for colon cancer.Keywords
Funding Information
- Kaohsiung Armed Forces General Hospital, Taiwan (KAFGH_D_111049)
- Ministry of Science and Technology, Taiwan (107-2314-B-650 -013 -; 108-2314-B-650 -010 -)
This publication has 55 references indexed in Scilit:
- Multifarious roles of sialic acids in immunityAnnals of the New York Academy of Sciences, 2012
- Sialylation of 3-Methylcholanthrene–Induced Fibrosarcoma Determines Antitumor Immune Responses during ImmunoeditingThe Journal of Immunology, 2010
- Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastomaInternational Journal of Cancer, 2006
- Neuronal Differentiation-dependent Expression of the Disialic Acid Epitope on CD166 and Its Involvement in Neurite Formation in Neuro2A CellsJournal of Biological Chemistry, 2002
- Molecular Cloning and Expression of a Sixth Type of α2,8-Sialyltransferase (ST8Sia VI) That SialylatesO-GlycansJournal of Biological Chemistry, 2002
- A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to α2,8-Disialyl and Branched α2,6-Sialyl ResiduesJournal of Biological Chemistry, 2002
- Identification and Adipocyte Differentiation-dependent Expression of the Unique Disialic Acid Residue in an Adipose Tissue-specific Glycoprotein, Adipo QJournal of Biological Chemistry, 2001
- Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progressionFEBS Letters, 2001
- Frequent Occurrence of Pre-existing α2→8-Linked Disialic and Oligosialic Acids with Chain Lengths Up to 7 Sia Residues in Mammalian Brain GlycoproteinsJournal of Biological Chemistry, 2000
- Sialyl-Tn, Sialyl-Lewis Xi, CA 19-9, CA 125, Carcinoembryonic Antigen, and Tissue Polypeptide Antigen in Differentiating Ovarian Cancer From Benign TumorsObstetrics & Gynecology, 1992